South African executive Gus Attridge loses $10 million as Aspen shares fall
South African pharma leader Gus Attridge sees a $10.7 million drop in his Aspen stake as the drugmaker’s shares slide and investor concerns deepen in 2025.
Gus Attridge
Skip to content
South African pharma leader Gus Attridge sees a $10.7 million drop in his Aspen stake as the drugmaker’s shares slide and investor concerns deepen in 2025.